Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cybin Inc. Common Shares (NY:CYBN)

6.030 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
41 42 Next >
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Adelia Marks Final Development Milestone
Via Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Pioneering Efforts as Studies, Research Show Psilocybin’s Potential in Treating AUD
Via Investor Brand Network
Topics Death
News headline image
Cybin Announces Final Adelia Milestone Achievement
From Cybin Inc.
Via Business Wire
News headline image
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression ↗
Cybin Inc. 
Via Benzinga
News headline image
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them ↗
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
Via Benzinga
News headline image
Compass Pathways, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.83% at $1.09 LOSERS: 
Via Benzinga
News headline image
7 Psychedelics Stocks to Buy for a Big Drug Boom ↗
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments 
Via InvestorPlace
BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Dosing Participants in CYB003 Trial for Treatment of MDD
Via Investor Brand Network
News headline image
Cybin Inc. Announces First Participants Dosed in its Phase 1/2a Trial of CYB003 for the Treatment of Major Depressive Disorder
From Cybin Inc.
Via Business Wire
News headline image
Small Pharma, Biomind Labs Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 27.51% at $0.18 
Via Benzinga
How Psychedelics Startups Are Improving Their Resilience
Via Investor Brand Network
News headline image
Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June ↗
The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD. 
Via Talk Markets
News headline image
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00 LOSERS: 
Via Benzinga
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Transformation of Psychedelic Sector
Via Investor Brand Network
Israeli Study identifies Bacterial Footprint in PTSD Sufferers
Via Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Participate in Upcoming H.C. Wainwright Global Investment Conference
Via Investor Brand Network
News headline image
Cybin to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
From Cybin Inc.
Via Business Wire
News headline image
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22 
Via Benzinga
How Meditation, Psychedelics Can Boost Healing
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From August 23, 2022 ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24 
Via Benzinga
News headline image
Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 10.34% at $0.16 
Via Benzinga
FT-104: Field Trip’s Latest Psychedelic Drug Candidate
Via Investor Brand Network
News headline image
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 29.35% at $0.14 LOSERS: 
Via Benzinga
News headline image
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session ↗
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
News headline image
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
  
Via Benzinga
Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From August 17, 2022 ↗
  
Via Benzinga
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Partner Receive Required Schedule I License from DEA for First-in-Human Clinical Trial
Via Investor Brand Network
News headline image
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression ↗
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) and Clinilabs Drug Development Corporation (Clinilabs) announced that the U.S. 
Via Benzinga
News headline image
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial
From Cybin Inc.
Via Business Wire
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.